Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income Statement
2024-07-01 to 2025-06-30
Revenue by Business Segment
2024-07-01 to 2025-06-30
Swipe to see the full flow
Chart details
Cardinal Health, Inc. (CAH) FY2025 Annual P&L / Income Statement
Income statement for 2024-07-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Revenue
- 222,578,000,000 US dollars
- Cost of products sold
- 214,410,000,000 US dollars
- Gross margin
- 8,168,000,000 US dollars
- Operating costs, net of other operating items (calculated)
- 5,893,000,000 US dollars
- Operating earnings
- 2,275,000,000 US dollars
- Other income (expense), net (calculated)
- negative 174,000,000 US dollars
- Earnings before income taxes
- 2,101,000,000 US dollars
- Income Tax Expense (Benefit)
- 532,000,000 US dollars
- Net earnings
- 1,569,000,000 US dollars
- GMPD
- 12,636,000,000 US dollars
- Other Operating Segment
- 5,382,000,000 US dollars
- Pharmaceutical and Specialty Solutions
- 204,644,000,000 US dollars
- Distribution, selling, general, and administrative expenses
- 5,382,000,000 US dollars
- Restructuring and employee severance
- 88,000,000 US dollars
- Amortization and other acquisition-related costs
- 464,000,000 US dollars
- Acquisition-related cash and share-based compensation costs [Line Items]
- 126,000,000 US dollars
- Impairments and (gain)/loss on disposal of assets, net
- 18,000,000 US dollars
- Litigation (recoveries)/charges, net
- negative 185,000,000 US dollars
- Revenue before reconciliation (calculated)
- 222,662,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Segment Reporting, Reconciling Item, Corporate Nonsegment
- negative 84,000,000 US dollars. Reported reconciliation to consolidated revenue.
- GMPD costs
- 12,501,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Other Operating Segment costs
- 4,866,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Pharmaceutical and Specialty Solutions costs
- 202,386,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 550,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to Cardinal Health, Inc.: $1.56 B; to noncontrolling interests: $8.00 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
3.7%
Gross profit / revenue
Operating margin
1.0%
Operating profit / revenue
Cash conversion
152.8%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
